1. Home
  2. XENE vs TNL Comparison

XENE vs TNL Comparison

Compare XENE & TNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • TNL
  • Stock Information
  • Founded
  • XENE 1996
  • TNL 1990
  • Country
  • XENE Canada
  • TNL United States
  • Employees
  • XENE N/A
  • TNL N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • TNL Hotels/Resorts
  • Sector
  • XENE Health Care
  • TNL Consumer Discretionary
  • Exchange
  • XENE Nasdaq
  • TNL Nasdaq
  • Market Cap
  • XENE 2.9B
  • TNL 3.3B
  • IPO Year
  • XENE 2014
  • TNL N/A
  • Fundamental
  • Price
  • XENE $39.36
  • TNL $60.31
  • Analyst Decision
  • XENE Strong Buy
  • TNL Buy
  • Analyst Count
  • XENE 11
  • TNL 10
  • Target Price
  • XENE $52.73
  • TNL $62.30
  • AVG Volume (30 Days)
  • XENE 747.4K
  • TNL 585.7K
  • Earning Date
  • XENE 11-11-2025
  • TNL 10-22-2025
  • Dividend Yield
  • XENE N/A
  • TNL 3.69%
  • EPS Growth
  • XENE N/A
  • TNL N/A
  • EPS
  • XENE N/A
  • TNL 5.78
  • Revenue
  • XENE $7,500,000.00
  • TNL $3,915,000,000.00
  • Revenue This Year
  • XENE N/A
  • TNL $4.17
  • Revenue Next Year
  • XENE $207.88
  • TNL $4.25
  • P/E Ratio
  • XENE N/A
  • TNL $10.50
  • Revenue Growth
  • XENE N/A
  • TNL 2.46
  • 52 Week Low
  • XENE $26.74
  • TNL $37.77
  • 52 Week High
  • XENE $46.00
  • TNL $64.12
  • Technical
  • Relative Strength Index (RSI)
  • XENE 56.70
  • TNL 46.10
  • Support Level
  • XENE $38.49
  • TNL $58.91
  • Resistance Level
  • XENE $40.17
  • TNL $62.71
  • Average True Range (ATR)
  • XENE 1.28
  • TNL 1.26
  • MACD
  • XENE 0.02
  • TNL -0.09
  • Stochastic Oscillator
  • XENE 67.55
  • TNL 30.00

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About TNL Travel Leisure Co. Common Stock

Travel+Leisure Co is a membership and leisure travel company. It provides hospitality services and travel products. The company operates in the segments of Vacation Ownership, which is the key revenue-driving segment, develops, markets and sells vacation ownership interests (VOIs) to individual consumers, provides consumer financing in connection with the sale of VOIs, and provides property management services at resorts, and Travel and Membership which operates a variety of travel businesses, including three vacation exchange brands, a home exchange network, travel technology platforms, travel memberships, and direct-to-consumer rentals. The majority of the revenue is earned from the United States.

Share on Social Networks: